Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine
Reference19 articles.
1. Ali A (2020) Delay in onabotulinumtoxinA treatment during the COVID-19 pandemic—perspectives from a virus hotspot. Headache. 60(6):1183–1186
2. López-Bravo A, García-Azorín D, Belvís R, González-Oria C, Latorre G, Santos-Lasaosa S et al (2020) Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives. Neurol (Engl Ed) 35(6):372–380
3. Santos-Lasaosa S, Porta-Etessam J (2020) OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection. Neurol (Engl Ed) 35(5):291–294
4. Szperka CL, Ailani J, Barmherzig R, Klein BC, Minen MT, Halker Singh RB et al (2020) Migraine care in the era of COVID-19: clinical pearls and plea to insurers. Headache. 60(5):833–842
5. Silvestro M, Tessitore A, Tedeschi G, Russo A (2020) Migraine in the time of COVID-19. Headache. 60(5):988–989
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献